Our Mission
MesoWatch exists to provide clear, accurate, and medically-reviewed information about mesothelioma to patients, families, and caregivers navigating this difficult diagnosis.
We believe everyone affected by mesothelioma deserves access to trustworthy information—without the influence of legal referral interests that dominate much of the online mesothelioma content landscape.
Why MesoWatch?
Search for mesothelioma information online, and you'll find countless websites that look like medical resources but exist primarily to connect patients with law firms. These sites often present incomplete or biased information designed to maximize legal lead generation.
MesoWatch takes a different approach. We focus on:
- Medical accuracy — Our content is based on peer-reviewed research, government health data, and established medical guidelines.
- Independence — We don't operate legal referral programs or accept compensation for connecting patients with attorneys.
- Transparency — We cite our sources and clearly distinguish between established facts and emerging research.
- Patient focus — Our content addresses what patients and families actually need to know, not what generates the most legal leads.
Our Content Standards
All MesoWatch content follows these principles:
- Information is sourced from peer-reviewed journals, government agencies (NIH, CDC, NCI), and established medical organizations
- Medical content is reviewed for accuracy
- Statistics include source citations
- We clearly label when information is preliminary or based on limited research
- Content is regularly updated as new research emerges
What We Cover
MesoWatch provides comprehensive information across the mesothelioma patient journey:
Disease Information
Types, symptoms, causes, staging, and prognosis
Treatment Options
Surgery, chemotherapy, immunotherapy, radiation, and clinical trials
Finding Care
Specialists, cancer centers, and getting second opinions
Research & Data
Statistics, emerging treatments, and clinical trial updates
Contact
Have questions or feedback? We'd like to hear from you.
Email: [email protected]